Familial hypercholesterolemia and triglyceride metabolism

International Journal of Cardiology

Volumn 147, Issue 3, 2011, Pages 349-358

  Kolovou, Genovefa D ^a   Kostakou, Peggy M ^a   Anagnostopoulou, Katherine K ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Atherosclerosis; Familial hypercholesterolemia; Familial hypercholesterolemia treatment; LDL apheresis; Triglyceride metabolism

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; ATORVASTATIN; BILE ACID SEQUESTRANT; CD36 ANTIGEN; CHOLESTEROL ESTER TRANSFER PROTEIN; COLESTILAN; COLESTYRAMINE; EZETIMIBE; FATTY ACID BINDING PROTEIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOSOME; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; NICOTINIC ACID; PECTIN; PHYTOSTEROL; POLYPHENOL; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

APHERESIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; EXERCISE; FAMILIAL HYPERCHOLESTEROLEMIA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID METABOLISM; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER TRANSPLANTATION; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VIRAL GENE DELIVERY SYSTEM;

EID: 79952487562     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.009     Document Type: Review

References (198)

1. L. Björn, T.P. Leren, L. Ose, A. Hamsten, and F. Karpe A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia Arterioscler Thromb Vasc Biol 20 2000 1784 1788 (Pubitemid 30470594)
2. G. Kolovou, D. Daskalova, I. Mastorakou, K. Anagnostopoulou, and D.V. Cokkinos Regression of Achilles tendon xanthomas evaluated by CT scan after hypolipidemic treatment with simvastatin Angiology 55 2004 335 339 (Pubitemid 38649700)
3. P.N. Hopkins Familial hypercholesterolemia-improving treatment and meeting guidelines Int J Cardiol 89 2003 13 23 (Pubitemid 36519173)
4. L. Ose An update on familial hypercholesterolaemia. Ann Med 1999; 31: 13-8., Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia Hum Mutat 1 1992 445 466
5. S.N. Pimstone, J.C. Defesche, S.M. Clee, H.D. Bakker, M.R. Hayden, and J.J. Kastelein Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia Arterioscler Thromb Vasc Biol 17 1997 826 833 (Pubitemid 27209258)
6. K.M. Timms, S. Wagner, and M.E. Samuels A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree Hum Genet 114 2004 349 353 (Pubitemid 38324948)
7. S.K. Mishra, S.C. Watkins, and L.M. Traub The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery Proc Natl Acad Sci USA 99 2002 16099 16104 (Pubitemid 35462755)
8. C.M. Ballantyne Familial hypercholesterolaemia: optimum treatment strategies Int J Clin Pract Suppl 130 2002 22 26 (Pubitemid 35024178)
9. J.L. Goldstein, H.H. Hobbs, and M.S. Brown Familial hypercholesterolemia C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, The metabolic and molecular bases of inherited disease 7th edn. 1995 McGraw-Hill Information Service Company USA 1981 2030
10. X.M. Sun, D.D. Patel, and J.C. Webb Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptornegative phenotype Arterioscler Thromb 14 1994 85 94
11. A.C. Jansen, S. van Wissen, J.C. Defesche, and J.J. Kastelein Phenotypic variability in familial hypercholesterolemia: an update Curr Opin Lipidol 13 2002 165 171 (Pubitemid 34280768)
12. E.S. Aalst-Cohen, A.C. Jansen, S. de Jongh, P.R. Sauvage Nolting, and J.J. Kastelein Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia Semin Vasc Med 4 2004 31 41 (Pubitemid 38393289)
13. G. Kolovou, D. Daskalova, and K. Anagnostopoulou Postprandial hypertriglyceridaemia in patients with Tangier disease J Clin Pathol 56 2003 937 941 (Pubitemid 37533238)
14. A.R. Sharrett, G. Heiss, and L.E. Chambless Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: the Atherosclerosis Risk In Communities (ARIC) study Arterioscler Thromb Vasc Biol 21 2001 275 281 (Pubitemid 32125378)
15. M.J. Malloy, and J.P. Kane A risk factor for atherosclerosis: triglyceride-rich lipoproteins Adv Intern Med 47 2001 111 136 (Pubitemid 33791976)
16. S. Boquist, G. Ruotolo, and R. Tang Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common intimamedia thickness in healthy, middle-aged men Circulation 100 1999 723 728 (Pubitemid 29383642)
17. F. Karpe, G. Steiner, K. Uffelman, T. Olivecrona, and A. Hamsten Postprandial lipoproteins and progression of coronary atherosclerosis Atherosclerosis 106 1994 83 97 (Pubitemid 24103802)
18. C.S. Uiterwaal, D.E. Grobbee, and J.C. Witteman Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis Ann Intern Med 121 1994 576 583
19. D.B. Zilversmit Atherogenesis: a postprandial phenomenon Circulation 60 1979 473 485 (Pubitemid 9254048)
20. M.S. Weintraub, I. Grosskopf, and T. Rassin Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years BMJ 312 1996 936 939
21. E. Meyer, H.T. Westerveld, and F.C. de Ruyter-Meijstek Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study Atherosclerosis 124 1996 221 235 (Pubitemid 26228009)
22. J.M. Chapman, M. Guerin, and E. Bruckert Role of anomalies of low density lipoproteins (LDL) in atherogenicity Bull Acad Natl Méd 185 2001 35 39
23. K.C. Tan, M.B. Cooper, and K.L. Ling Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance Atherosclerosis 113 1995 273 287
24. J.S. Cohn, E.J. Johnson, and J.S. Millar Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters J Lipid Res 34 1993 2033 2040 (Pubitemid 24000952)
25. B.O. Schneeman, L. Kotite, K.M. Todd, and R.J. Havel Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans Proc Natl Acad Sci USA 90 1993 2069 2073 (Pubitemid 23069999)
26. C.J. Fielding Lipoprotein receptors, plasma cholesterol metabolism, and the regulation of cellular free cholesterol concentration FASEB J 6 1992 3162 3168
27. J.C.L. Μamo Atherosclerosis as a post-prandial disease Endocrinor met 2 1995 229 244 (Pubitemid 26024043)
28. A.D. Cooper Hepatic uptake of chylomicron remnants J Lipid Res 38 1997 2173 2192 (Pubitemid 27495377)
29. G.R. Thompson, R.P. Naoumova, and G.F. Watts Role of cholesterol in regulating apolipoprotein B secretion by the liver J Lipid Res 37 1996 439 447 (Pubitemid 26134353)
30. D.C. Chan, G.F. Watts, P.H. Barrett, F.H. O'Neill, T.G. Redgrave, and G.R. Thompson Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome Clin Sci 104 2003 383 388 Lond (Pubitemid 36458064)
31. A.F. Ayyobi, and J.D. Brunzell Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia Am J Cardiol 92 2003 J27 J33
32. R.W. Mahley, T.L. Innerarity, S.C. Rall, and K.H. Weisgraber Plasma lipoproteins: apolipoprotein structure and function J Lipid Res 25 1984 1277 1294 (Pubitemid 15150638)
33. T.L. Innerarity, R.E. Pitas, and R.W. Mahley Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptor of fibroblasts J Biol Chem 254 1979 4186 4190
34. M.M. Hussain, T.L. Innerarity, W.J. Brecht, and R.W. Mahley Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidaemic rabbits. Saturation of the sequestration step of the remnant clearance pathway J Biol Chem 270 1995 8578 8587
35. T.E. Willnow, Z. Sheng, S. Ishibashi, and J. Herz Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist Science 264 1994 1471 1474 (Pubitemid 24217140)
36. M. Lechleitner, F. Hoppichler, B. Föger, and J.R. Patsch Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages Arterioscl Thromb 14 1994 1799 1807
37. S. Jäckle, F. Rinninger, J. Greeve, H. Greten, and E. Windler Regulation of the hepatic removal of chylomicron remnants and β-very low density lipoproteins in the rat J Lipid Res 33 1992 419 429
38. B. Skrede, R. Blomhoff, G.M. Maelandsmo, L. Ose, O. Myklebost, and K.R. Norum Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo Eur J Clin Invest 22 1992 229 234
39. M. Eriksson, G. Angelin, P. Henriksson, S. Ericsson, S. Vitols, L. Berglund 827-37 Metabolism of lipoprotein remnants in humans. Studies during intestinal infusion of fat and cholesterol in subjects with varying expression of the low density lipoprotein receptor Arterioscler Thromb 11 1991 827 837
40. A. Bowler, T.G. Redgrave, and J.C.L. Mamo chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor Biochem J 276 1991 381 386
41. S.Y. Choi, L.G. Fong, M.J. Kirven, and A.D. Cooper Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo J Clin Invest 88 1991 1173 1181
42. D.C. Rubinsztein, J.C. Cohen, M. Berger, D.R. van der Westhuyzen, G.A. Coetzee, and W. Gevers Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolaemic homozygotes with defined receptor defects J Clin Invest 86 1990 1306 1312 (Pubitemid 20370439)
43. S.L. Herd, B. Kiens, L.H. Boobis, and A.E. Hardman Moderate exercise, postprandial lipemia, and skeletal muscle lipoprotein lipase activity Metabolism 50 2001 756 762 (Pubitemid 32700452)
44. S.W. Coppack, R.M. Fisher, and G.F. Gibbons Postprandial substrate deposition in human forearm and adipose tissues in vivo Clin Sci 79 1990 339 348 (Pubitemid 20331470)
45. F. Karpe, M. Bell, J. Bjorkegren, and A. Hamsten Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100 Arterioscler Thromb Vasc Biol 15 1995 199 207
46. F. Karpe, T. Olivecrona, A. Hamsten, and M.J. Hultin Chylomicron/ chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants Lipid Res 38 1997 949 961 (Pubitemid 27255203)
47. R. Fraser, W.J. Cliff, and F.C. Courtice The effect of dietary fat load on the size and composition of chylomicrons in thoracic duct lymph Q J Exp Physiol Cogn Med Sci 53 1968 390 398
48. F. Karpe Postprandial lipid metabolism in relation to coronary heart disease Proc Nutr Soc 56 1997 671 678 (Pubitemid 127761213)
49. M.J. Caslake, C.J. Packard, and A. Gaw Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia J Arterioscler Thromb 13 1993 702 711 (Pubitemid 23141760)
50. J. Shepherd Mechanism of action of fibrates Postgrad Med J 69 1993 S34 S41
51. Barter J., H.B. Brewer Jr, M.J. Chapman, C.H. Hennekens, D.J. Rader, and A.R. Tall Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 160 167 (Pubitemid 36231923)
52. A.R. Tall Plasma cholesteryl ester transfer protein J Lipid Res 34 1993 1255 1274 (Pubitemid 23230305)
53. M. Guerin, W. Le Goff, T.S. Lassel, A. Van Tol, G. Steiner, and M.J. Chapman Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemiα Arterioscler Thromb Vasc Biol 21 2001 282 288 (Pubitemid 32125379)
54. C. Contacos, P.J. Barter, L. Vrga, and D.R. Sullivan Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin Atherosclerosis 141 1998 87 98 (Pubitemid 28539419)
55. A. Tall, D. Sammett, and E. Granot Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia J Clin Invest 77 1986 1163 1172 (Pubitemid 16047136)
56. G.R. Castro, and C.J. Fielding Effects of postprandial lipemia on plasma cholesterol metabolism J Clin Invest 75 1985 874 882 (Pubitemid 15111012)
57. M. Guerin, P. Egger, and C. Soudant Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state J Lipid Res 43 2002 1652 1660 (Pubitemid 35168279)
58. G.R. Castro, and C.J. Fielding Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein Biochemistry 27 1988 25 29 (Pubitemid 18036281)
59. B. Lamarch, S. Rashid, and G.F. Lewis HDL metabolism in hypertriglyceridemic states: an overview Clin Chim Acta 286 1999 145 161 (Pubitemid 29406105)
60. J.D. Brunzell, and J.E. Hokanson Dyslipidemia of central obesity and insulin resistance Diab Care 22 1999 C10 C13
61. B. Angelin Metabolism of endogenous plama triglyceride in familial hypercholesterolaemia: studies of affected and unaffected siblings of two kindreds Eur J Clin Invest 10 1980 23 26 (Pubitemid 10133846)
62. M.H. Cummings, G.F. Watts, M. Umpleby, T.R. Hennessy, J.R. Quiney, and P.H. Sonksen Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study Atherosclerosis 113 1995 79 89
63. P. Degrace, B. Moindrot, and I. Mohamed Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10, cis-12 conjugated linoleic acid J Lipid Res 47 2006 2647 2655 (Pubitemid 44936078)
64. A.J. Tremblay, B. Lamarche, and I.L. Ruel Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the samenullLDLreceptor genemutation J Lipid Res 45 2004 866 872 (Pubitemid 38552856)
65. J.D. Horton, H. Shimano, R.L. Hamilton, M.S. Brown, and J.L. Goldstein Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL J Clin Invest 103 1999 1067 1076 (Pubitemid 29169615)
66. W.T. Liao, Y. Hui, S.G. Young, and R.A. Davis Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER J Lipid Res 44 2003 978 985 (Pubitemid 37279657)
67. J. Twisk, D.L. Gillian-Daniel, A. Tebon, L. Wang, P.H. Barrett, and A.D. Attie The role of the LDL receptor in apolipoprotein B secretion J Clin Invest 105 2000 521 532
68. D.L. Gillian-Daniel, P.W. Bates, A. Tebon, and A.D. Attie Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B Proc Natl Acad Sci USA 99 2002 4337 4342 (Pubitemid 34285986)
69. J.S. Millar, C. Maugeais, I.V. Fuki, and D.J. Rader Normal production rate of apolipoprotein B in LDL receptor-deficient mice Arterioscler Thromb Vasc Biol 22 2002 989 994 (Pubitemid 34655228)
70. J.S. Millar, C. Maugeais, and K. Ikewaki Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production Arterioscler Thromb Vasc Biol 25 2005 560 565 (Pubitemid 40315678)
71. A.K. Soutar, N.B. Myant, and G.R. Thompson The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia Atherosclerosis 43 1982 217 231 (Pubitemid 12073490)
72. A.K. Soutar, N.B. Myant, and G.R. Thompson Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemia Atherosclerosis 28 1977 247 256 (Pubitemid 8225231)
73. R. Uauy, G.L. Vega, S.M. Grundy, and D.M. Bilheimer Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover J Pediatr 113 1988 387 392
74. W.R. Fisher, L.A. Zech, and P.W. Stacpoole ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm Arterioscler Thromb 14 1994 501 510
75. W.R. Fisher, L.A. Zech, L.L. Kilgore, and P.W. Stacpoole Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer J Lipid Res 32 1991 1823 1836
76. R.W. James, B. Martin, and D. Pometta Apolipoprotein B metabolism in homozygous familial hypercholesterolemia J Lipid Res 30 1989 159 169 (Pubitemid 19067221)
77. H.R. Zulewski, A.R. Ninnis, M. Miserez, W. Baumstark, and U. Keller VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100 J Lipid Res 39 1998 380 387 (Pubitemid 28100675)
78. G.D. Kolovou, and H.G. Bilianou Influence of aging and menopause on lipids and lipoproteins in women Angiology 59 2008 54S 57S
79. G.D. Kolovou, K.K. Anagnostopoulou, and D.S. Damaskos Gender differences in the lipid profile of dyslipidemic subjects Eur J Intern Med 20 2009 145 151
80. G.D. Kolovou, K.K. Anagnostopoulou, and A.N. Pavlidis Metabolic syndrome and gender differences in postprandial lipaemia Eur J Cardiovasc Prev Rehabil 13 2006 661 664 (Pubitemid 44162173)
81. M. Febbraio, N.A. Abumrad, D.P. Hajjar, K. Sharma, W. Cheng, S.F. Pearce, and R.L. Silverstein A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism J Biol Chem 274 1999 19055 19062
82. H. Yagyu, E.P. Lutz, and Y. Kako Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency J Biol Chem 277 2002 10037 10043 (Pubitemid 34968113)
83. H.L. Dichek, S.M. Johnson, and H. Akeefe Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice J Lipid Res 42 2001 201 210 (Pubitemid 32206831)
84. C. Jones, R. Garuti, and P. Michaely Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia J Clin Invest 117 2007 165 174 (Pubitemid 46048463)
85. L. Pisciotta, C. Priore Oliva, and G.M. Pes Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison Atherosclerosis 188 2006 398 405 (Pubitemid 44301145)
86. R.P. Naoumova, C. Neuwirth, P. Lee, J.P. Miller, K.G. Taylor, and A.K. Soutar Autosomal recessive hypercholesterolaemia: long-term follow up and response to treatment Atherosclerosis 174 2004 165 172 (Pubitemid 38595453)
87. R. Fellin, G. Zuliani, and M. Arca Clinical and biochemical characterization of patients with autosomal recessive hypercholesterolemia (ARH) Nutr Metab Cardiovasc Dis 13 2003 278 286 (Pubitemid 38622732)
88. M. Arca, G. Zuliani, and K. Wilund Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis Lancet 359 2002 841 847 (Pubitemid 34233756)
89. E. Eden, R. Naoumova, J. Burden, M. McCarthy, and A. Soutar Use of homozygosity mapping to identify a region on chromosome 1 bearing a defective gene that causes autosomal recessive homozygous hypercholesterolemia in two unrelated families Am J Hum Genet 68 2001 653 660 (Pubitemid 32202760)
90. D. Norman, X.M. Sun, M. Bourbon, B.L. Knight, R.P. Naoumova, and A.K. Soutar Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia J Clin Invest 104 1999 619 628
91. H.H. Schmidt, M. Stuhrmann, and R. Shamburek Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDLreceptor in a subject with clinical homozygous familial hypercholesterolemia J Clin Endocrinol Metab 83 1998 2167 2174 (Pubitemid 28496355)
92. G. Zuliani, G.B. Vigna, A. Corsini, M. Maioli, F. Romagnoni, and R. Fellin Severe hypercholesterolaemia:unusual inheritance in an Italian pedigree Eur J Clin Invest 25 1995 322 331
93. A.K. Khachadurian, and S.M. Uthman Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients Nutr Metab 15 1973 132 140
94. D. Takada, Y. Ezura, and S. Ono Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family Atheroscler Thromb 10 2003 79 84
95. G. Kolovou, D. Daskalova, and D.P. Mikhailidis Apolipoprotein E polymorphism and atherosclerosis Angiology 54 2003 59 71 (Pubitemid 36222543)
96. T.C. Ooi, M. Cousins, and D.S. Ooi Postprandial remnant-like lipoproteins in hypertriglyceridemia J Clin Endocrinol Metab 86 2001 3134 3142 (Pubitemid 32673477)
97. J.M. Ordovas Genetics, postprandial lipemia and obesity Nutr Metab Cardiovasc Dis 11 2001 118 133 (Pubitemid 33687816)
98. E. Levy, D. Menard, and E. Delvin The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants J Biol Chem 276 2001 39679 39684
99. I.O. Ottestad, B. Halvorsen, and T.R. Balstad Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux J Nutr 136 2006 877 881
100. N.A. Le, P.M. Coates, P.R. Gallagher, and J.A. Cortner Kinetics of retinyl esters during postprandial lipemia in man: a compartmental model Metabolism 46 1997 584 594 (Pubitemid 27214885)
101. K.K. Anagnostopoulou, G.D. Kolovou, and P.M. Kostakou Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia Lipids Health Dis 8 2009 24
102. G.D. Kolovou, K.K. Anagnostopoulou, and D.S. Damaskos Gender influence on postprandial lipemia in heterozygotes for familial hypercholesterolemia Ann Clin Lab Sci 37 2007 335 342 (Pubitemid 350105934)
103. G.D. Kolovou, K.K. Anagnostopoulou, S.S. Daskalopoulou, D.P. Mikhailidis, and D.V. Cokkinos Clinical relevance of postprandial lipaemia Curr Med Chem 12 2005 1931 1945 (Pubitemid 41015175)
104. G.D. Kolovou, K.K. Anagnostopoulou, and N.D. Pilatis Heterozygote men with familial hypercholesterolaemia may have an abnormal triglyceride response post-prandially. Evidence for another predictor of vascular risk in familial hypercholesterolaemia Int J Clin Pract 59 2005 311 317 (Pubitemid 40352748)
105. G.D. Kolovou, K.K. Anagnostopoulou, and N.D. Pilatis The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia J Womens Health (Larchmt) 13 2004 1119 1126
106. C.A. Dane-Stewart, G.F. Watts, J.C. Mamo, S.B. Dimmitt, P.H. Barrett, and T.G. Redgrave Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia Eur J Clin Invest 31 2001 113 117 (Pubitemid 32199903)
107. M.C. Cabezas, T.W. de Bruin, H.E. Westerveld, E. Meijer, and D.W. Erkelens Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia J Intern Med 244 1998 299 307 (Pubitemid 28473993)
108. J.C. Mamo, D. Smith, and K.C. Yu Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia Eur J Clin Invest 28 1998 379 384 (Pubitemid 28261221)
109. R.W. Mahley, and T.L. Innerarity Lipoprotein receptors and cholesterol homeostasis Biochem Biophys Acta 737 1983 197 222 (Pubitemid 13086955)
110. G.F. Watts, P.H. Barrett, and A.D. Matais Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test Atherosclerosis 157 2001 519 523 (Pubitemid 32710033)
111. J.C. Firth, and A.D. Marais Familial hypercholesterolaemia: the Cape Town experience S Afr Med J 98 2008 99 104 (Pubitemid 351356313)
112. G.V. Dedoussis, S. Maumus, and D.M. Choumerianou Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients Genet Test 10 2006 192 199 (Pubitemid 44856601)
113. G. Kolovou, K. Anagnostopoulou, and D.P. Mikhailidis One century of triglycerides, but there is still lots to learn! Curr Drug Targets 10 2009 299 301
114. M.F. Oliver, and M.J. Davies The atheromatous lipid core Eur Heart J 19 1998 16 18 (Pubitemid 28112297)
115. University College London Medical School Hypertriglyceridaemia and vascular risk. Report of a meeting of physicians and scientists Lancet 342 1993 781 787
116. J. Funada, M. Sekiya, M. Hamada, and K. Hiwada Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction Circ J 66 2002 127 132 (Pubitemid 34464718)
117. A. Jagla, and J. Schrezenmeir Postprandial triglycerides and endothelial function Exp Clin Endocrinol Diab 109 2001 S533 S547
118. N. Gokce, S.J. Duffy, L.M. Hunter, J.F. Keaney, and J.A. Vita Acute hypertriglyceridemia is associated with peripheral vasodilation and increased basal flow in healthy young adults Am J Cardiol 88 2001 153 159 (Pubitemid 32607701)
119. J.H. Bae, E. Bassenge, and K.B. Kim Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress Atherosclerosis 155 2001 517 523 (Pubitemid 32209324)
120. A. Kondo, Y. Muranaka, and I. Ohta Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL Clin Chem 47 2001 893 900 (Pubitemid 32398041)
121. B. Lamarche, A. Tchernof, and S. Moorjani Small, dense lowdensity lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study Circulation 95 1997 69 75 (Pubitemid 27029945)
122. B.A. Griffin, D.J. Freeman, and G.W. Tait Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk Atherosclerosis 106 1994 241 253 (Pubitemid 24188766)
123. M. Miller Differentiating the effects of raising low levels of highdensity lipoprotein cholesterol versus lowering normal triglycerides:further insights from the Veterans Affairs High-Density Lipoprotein Intervention Trial Am J Cardiol 86 2000 23L 27L
124. A. Wiegman, J. Rodenburg, and S. de Jongh Family history and cardiovascular risk in familial hypercholesterolemia. Data in more than 1000 children Circulation 107 2003 1473 1478 (Pubitemid 36378483)
125. G.F. Watts Postprandial lipaemia in familial hypercholesterolaemia: clinical and metabolic significance Atherosclerosis 148 2000 426 428 (Pubitemid 30064476)
126. A.D. Cooper, R. Nutik, and J. Chen Characterization of the estrogen-induced lipoprotein receptor of rat liver J Lipid Res 28 1987 59 86
127. G.D. Kolovou, K.K. Anagnostopoulou, and K.D. Salpea Postprandial lipemia in postmenopausal women with high fasting high-density lipoprotein cholesterol Am J Med Sci 331 2006 10 16 (Pubitemid 43177509)
128. D.K. Spady, L.A. Woollett, and J.M. Dietschy Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids Annu Rev Nutr 13 1993 355 381 (Pubitemid 23227789)
129. K. Higuchi, K. Kitagawa, K. Kogishi, and T. Takeda Developmental and age-related changes in apolipoprotein B mRNA editing in mice J Lipid Res 33 1992 1753 1764 (Pubitemid 23006652)
130. L. Chan, and B. Apolipoprotein The major protein component of triglyceride-rich and low density lipoproteins J Biol Chem 267 1992 25621 25624 (Pubitemid 23013946)
131. J. Scott The molecular and cell biology of apolipoprotein-B Mol Biol Med 6 1989 65 80 (Pubitemid 19152029)
132. F.M. Van't Hooft, D.A. Hardman JP, and R.J. Kane Havel Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins Proc Natl Acad Sci U S A 79 1982 179 182
133. Y. Watanabe, T. Ito, and M. Shiomi The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits. An animal model for familial hypercholesterolemia Atherosclerosis 56 1985 71 79 (Pubitemid 15049650)
134. D. Barcat, A. Amadio, and A. Palos-Pinto Combined hyperlipidemia/ hyperalphalipoproteinemia associated with premature spontaneous atherosclerosis in mice lacking hepatic lipase and low density lipoprotein receptor Atherosclerosis 188 2006 347 355 (Pubitemid 44301146)
135. W. Shi, X. Wang, and J. Wong Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice Biochem Biophys Res Commun 317 2004 223 229 (Pubitemid 38401988)
136. C. Napoli, F. de Nigris, and J.S. Welch Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray Circulation 105 2002 1360 1367 (Pubitemid 34260429)
137. S. Ishibashi, M.S. Brown, J.L. Goldstein, R.D. Gerard, R.E. Hammer, and J. Herz Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery J Clin Invest 92 1993 883 893 (Pubitemid 23262411)
138. C. Knouff, O. Briand, S. Lestavel, V. Clavey, M. Altenburg, and N. Maeda Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor Biochim Biophys Acta 1684 2004 8 17 (Pubitemid 39140864)
139. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47 (Pubitemid 16037973)
140. J.J. Repa, S.D. Turley, G. Quan, and J.M. Dietschy Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption J Lipid Res 46 2005 779 789 (Pubitemid 43073288)
141. M. Yoon, S. Jeong, and H. Lee Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice Biochem Biophys Res Commun 302 2008 29 34 (Pubitemid 36268914)
142. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Programme (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adult Treatment Panel III) JAMA 285 2001 2486 2497
143. R.J. Nicolosi, A.F. Stucchi, M.C. Kowala, L.K. Hennessy, D.M. Hegsted, and E.J. Schaefer Effect of dietary fat saturation and cholesterol on LDL composition and metabolism Arteriosclerosis 10 1990 119 128
144. J.C. Fox, H.C. McGill Jr, K.D. Carey, and G.S. Getz In vivo regulation of hepatic LDL receptor mRNA in the baboon: differentia] effects of saturated and unsaturated fat J Biol Chan 262 1987 7014 7020
145. D.K. Spady, and J.M. Dietschy Dietary saturated trigrycerides suppress hepatic low density lipoprotein receptors in the hamster Proc Natl Acad Sci USA 82 1985 4526 4530 (Pubitemid 15233153)
146. B.W. McCrindle, E.M. Urbina, and B.A. Dennison American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee; American Heart Association Council of Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Nursing. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing Circulation 115 2007 1948 1967
147. C.J. Glueck, M.J. Mellies, M. Dine, T. Perry, and P. Laskarzewski Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia Pediatrics 78 1986 338 348 (Pubitemid 16039568)
148. B.T. Metzger, D.M. Barnes, and J.D. Reed A comparison of pectin, polyphenols, and phytosterols, alone or in combination, to lovastatin for reduction of serum lipids in familial hypercholesterolemic swine J Med Food 12 2009 854 860
149. F. Fuentes, J. López-Miranda, and A. García Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia Eur J Clin Nutr 62 2008 495 501
150. K.G. Moruisi, W. Oosthuizen, and A.M. Opperman Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis J Am Coll Nutr 25 2006 41 48 (Pubitemid 46939861)
151. L. Jakulj, M.N. Vissers, J. Rodenburg, A. Wiegman, M.D. Trip, and J.J. Kastelein Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels J Pediatr 148 2006 495 500
152. J. Quílez, P. Garcí-Lorda, and J. Salas-Salvadó Potential uses and benefits of phytosterols in diet: present situation and future directions Clin Nutr 22 2003 343 351 (Pubitemid 37063294)
153. D. Weghuber, and K. Widhalm Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet Br J Nutr 99 2008 281 286
154. K. Tolfrey, A.M. Jones, and I.G. Campbell The effect of aerobic exercise training on the lipid-lipoprotein profile of children and adolescents Sports Med 29 2000 99 112 (Pubitemid 30110382)
155. S.R. Daniels Exercise and lipid abnormalities Pediatr Cardiol 20 1999 71 77
156. P.T. Katzmarzyk, R.M. Malina, and C. Bouchard Physical activity, physical fitness, and coronary heart disease risk factors in youth: the Quebec Family Study Prev Med 29 1999 555 562 (Pubitemid 30026551)
157. K. Tolfrey, I.G. Campbell, and A.M. Jones Selected predictor variables and the lipid-lipoprotein profile of prepubertal girls and boys Med Sci Sports Exerc 31 1999 1550 1557
158. K. Tolfrey, I.G. Campbell, and A.M. Batterham Exercise training induced alterations in prepubertal children's lipid-lipoprotein profile Med Sci Sports Exerc 30 1998 1684 1692 (Pubitemid 29010991)
159. J.C. Eisenmann Blood lipids and lipoproteins in child and adolescent athletes Sports Med 32 2002 297 307 (Pubitemid 34450634)
160. A.D. Marais, J.C. Firth, M.E. Bateman, P. Byrnes, C. Martens, and J. Mountney Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia Arterioscler Thromb Vasc Biol 17 1997 1527 1531 (Pubitemid 27387773)
161. S.G. Tsouli, V. Xydis, M.I. Argyropoulou, A.D. Tselepis, M. Elisaf, and D.N. Kiortsis Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study Atherosclerosis 205 2009 151 155
162. J.J. Kastelein, A. Wiegman, and E. de Groot Surrogate markers of atherosclerosis: impact of statins Atheroscler Suppl 4 2003 31 36 (Pubitemid 38234505)
163. R.D. Santos, A.P. Chacra, A. Morikawa, C.C. Vinagre, and R.C. Maranhão Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin Lipids 40 2005 737 743 (Pubitemid 41266313)
164. N. Shafiq, B. Bhasin, and S. Pattanaik A meta-analysis to evaluate the efficacy of statins in children with familial hypercholesterolemia Int J Clin Pharmacol Ther 45 2007 548 555 (Pubitemid 47527454)
165. M.-C. Vohl, F. Szots, and M. Lelièvre Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia Atherosclerosis 160 2002 361 368 (Pubitemid 34159329)
166. F.J. Chaves, J.T. Real, and A.B. García-García Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol J Clin Endocrinol Metab 86 2001 4926 4932 (Pubitemid 33020543)
167. X.-M. Sun, D.D. Patel, B.L. Knight, and A.K. Soutar for the Familial Hypercholesterolaemia Regression Study Group. Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia Atherosclerosis 136 1998 175 185 (Pubitemid 28341456)
168. K. Kajinami, K. Yagi, T. Higashikata, A. Inazu, J. Koizumi, and H. Mabuchi Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia Am J Cardiol 82 1998 113 117 (Pubitemid 28322042)
169. A.F. Vuorio, J.-P. Ojala, S. Sarna, H. Turtola, M.J. Tikkanen, and K. Kontula Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment J Intern Med 237 1995 43 48
170. M. Jeenah, W. September, Roggen F. Graadt van, W. de Villiers, H. Seftel, and D. Marais Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia Atherosclerosis 98 1993 51 58 (Pubitemid 23010423)
171. E. Leitersdorf, S. Eisenberg, and O. Eliav Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia Circulation 87 1993 III35 III44 (Pubitemid 23097056)
172. K.C. Koeijvoets, J. Rodenburg, B.A. Hutten, A. Wiegman, J.J. Kastelein, and E.J. Sijbrands Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial Circulation 112 2005 3168 3173 (Pubitemid 43113445)
173. M.A. Kawashiri, T. Higashikata, and A. Nohara Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH) Circ J 69 2005 515 520 (Pubitemid 40745722)
174. S. Lind, A.G. Olsson, M. Eriksson, M. Rudling, G. Eggertsen, and B. Angelin Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment J Intern Med 256 2004 406 412 (Pubitemid 39434377)
175. N. Masaki, R. Tatami, and T. Kumamoto Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy Int Heart J 46 2005 833 843
176. M. Coker, S.K. Ucar, D.G. Simsek, S. Darcan, M. Bak, and S. Can Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia Ther Apher Dial 13 2009 121 128
177. H. Makino, and M. Harada-Shiba Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia Ther Apher Dial 7 2003 397 401 (Pubitemid 37082026)
178. G.D. Kolovou, G.V. Dedoussis, and K.K. Anagnostopoulou Management of a patient with a null low-density lipoprotein receptor mutation: a case report Angiology 57 2006-2007 729 732 (Pubitemid 44968834)
179. A. Yamamoto, M. Harada-Shiba, and M. Endo The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy Atherosclerosis 186 2006 126 131
180. N. Koga Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia Ther Apher 5 2001 244 251 (Pubitemid 33062671)
181. G.R. Thompson LDL apheresis Atherosclerosis 167 2003 1 13 (Pubitemid 36258395)
182. Thompson GR; HEART-UK LDL Apheresis Working Group Recommendations for the use of LDL apheresis Atherosclerosis 198 2008 247 255
183. J. Li, B. Fang, and R.C. Eisensmith In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene J Clin Invest 95 1995 768 773
184. K.F. Kozarsky, D.R. McKinley, L.L. Austin, S.E. Raper, L.D. Stratford-Perricaudet, and J.M. Wilson In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses J Biol Chem 269 1994 13695 13702 (Pubitemid 24206152)
185. J.R. Chowdhury, M. Grossman, S. Gupta, N.R. Chowdhury, J.R. Baker Jr, and J.M. Wilson Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits Science 254 1991 1802 1805 (Pubitemid 21917532)
186. M. Grossman, S.E. Raper, and K. Kozarsky Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia Nat Genet 6 1994 335 341 (Pubitemid 24190015)
187. M. Shichiri, A. Tanaka, and Y. Hirata Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex Gene Ther 10 2003 827 831 (Pubitemid 36621829)
188. N. Tomita, R. Morishita, and H. Koike Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse Int J Mol Med 10 2002 137 143
189. K. Kobayashi, K. Oka, and T. Forte Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor J Biol Chem 271 1996 6852 6860 (Pubitemid 26104786)
190. K.F. Kozarsky, K. Jooss, M. Donahee, J.F. Strauss 3rd, and J.M. Wilson Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene Nat Genet 13 1996 54 62 (Pubitemid 26139294)
191. K. Oka, L. Pastore, and I.H. Kim Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor Circulation 103 2001 1274 1281 (Pubitemid 32221352)
192. S. Takahashi, J. Sakai, and T. Fujino The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor J Atheroscler Thromb 11 2004 200 208
193. H.H. Schmidt, U.J. Tietge, and J. Buettner Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation Clin Transplant 22 2008 180 184 (Pubitemid 351420011)
194. B.J. Alkofer, L. Chiche, and A. Khayat Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature Transplant Proc 37 2005 2250 2252 (Pubitemid 40956423)
195. M. López-Santamaria, L. Migliazza, and M. Gamez Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass J Pediatr Surg 35 2000 630 633 (Pubitemid 30181048)
196. F. Kakaei, S. Nikeghbalian, and K. Kazemi Liver transplantation for homozygous familial hypercholesterolemia: two case reports Transplant Proc 41 2009 2939 2941
197. C. Liu, D.M. Niu, and C.C. Loong Domino liver graft from a patient with homozygous familial hypercholesterolemia Pediatr Transplant 2009 [Epub ahead of print]
198. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150